Nigeria vs Peru: Previously treated cases tested for RR-/MDR-TB
Nigeria
95.0%
in 2024
Peru
95.0%
in 2024
Nigeria rank
66th
Peru rank
66th
Previously treated cases tested for RR-/MDR-TB over time
- Nigeria
- Peru
How they compare
Nigeria currently reports 95.0% against 95.0% in Peru, a difference of 0.0%.
The two have swapped places 2 times across 15 shared years of data; in 2007 it was Peru ahead.
Nigeria ranks 66th and Peru ranks 66th of 180 countries.
Across the 3 decades both report, Nigeria averaged higher in 1 and Peru in 2.
Head to head by decade
| Decade | Nigeria | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.4% | 22.7% | 22.2% | Peru |
| 2010s | 55.6% | 65.4% | 9.8% | Peru |
| 2020s | 94.8% | 82.4% | 12.4% | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Nigeria or Peru?
- Nigeria, at 95.0% against 95.0% in Peru as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Nigeria and Peru?
- 0.0%, with Nigeria ahead.
- How many years of comparable data are there for Nigeria and Peru?
- 15 years are reported by both, from 2007 to 2024.
- How do Nigeria and Peru rank globally for previously treated cases tested for rr-/mdr-tb?
- Nigeria ranks 66th and Peru ranks 66th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.